Oseltamivir for influenza

Research output: Contribution to journalLetterResearchpeer-review

2 Citations (Scopus)

Abstract

[Extract] In their Article (May 2, p 1729) on oseltamivir treatment for influenza, Joanna Dobson and colleagues reported both fewer admittances to hospital for those treated with oseltamivir in the subgroup of patients classified as infected and fewer lower respiratory tract complications in patients treated with antibiotics as a surrogate for severity than in placebo recipients. However, our Cochrane review found insufficient evidence of a difference between groups for complications classified as serious or leading to patient withdrawal, or for rate of admittance to hospital.
Original languageEnglish
Pages (from-to)1133-1134
Number of pages2
JournalThe Lancet
Volume386
Issue number9999
DOIs
Publication statusPublished - 19 Sep 2015

Fingerprint

Oseltamivir
Human Influenza
Respiratory System
Placebos
Anti-Bacterial Agents
Therapeutics

Cite this

Jones, Mark ; Hama, Rokuro ; Del Mar, Chris. / Oseltamivir for influenza. In: The Lancet. 2015 ; Vol. 386, No. 9999. pp. 1133-1134.
@article{92bb1bcd6d714b6c87acd736073bdbe1,
title = "Oseltamivir for influenza",
abstract = "[Extract] In their Article (May 2, p 1729) on oseltamivir treatment for influenza, Joanna Dobson and colleagues reported both fewer admittances to hospital for those treated with oseltamivir in the subgroup of patients classified as infected and fewer lower respiratory tract complications in patients treated with antibiotics as a surrogate for severity than in placebo recipients. However, our Cochrane review found insufficient evidence of a difference between groups for complications classified as serious or leading to patient withdrawal, or for rate of admittance to hospital.",
author = "Mark Jones and Rokuro Hama and {Del Mar}, Chris",
year = "2015",
month = "9",
day = "19",
doi = "10.1016/S0140-6736(15)00200-7",
language = "English",
volume = "386",
pages = "1133--1134",
journal = "Lancet",
issn = "0140-6736",
publisher = "Elsevier",
number = "9999",

}

Oseltamivir for influenza. / Jones, Mark; Hama, Rokuro; Del Mar, Chris.

In: The Lancet, Vol. 386, No. 9999, 19.09.2015, p. 1133-1134.

Research output: Contribution to journalLetterResearchpeer-review

TY - JOUR

T1 - Oseltamivir for influenza

AU - Jones, Mark

AU - Hama, Rokuro

AU - Del Mar, Chris

PY - 2015/9/19

Y1 - 2015/9/19

N2 - [Extract] In their Article (May 2, p 1729) on oseltamivir treatment for influenza, Joanna Dobson and colleagues reported both fewer admittances to hospital for those treated with oseltamivir in the subgroup of patients classified as infected and fewer lower respiratory tract complications in patients treated with antibiotics as a surrogate for severity than in placebo recipients. However, our Cochrane review found insufficient evidence of a difference between groups for complications classified as serious or leading to patient withdrawal, or for rate of admittance to hospital.

AB - [Extract] In their Article (May 2, p 1729) on oseltamivir treatment for influenza, Joanna Dobson and colleagues reported both fewer admittances to hospital for those treated with oseltamivir in the subgroup of patients classified as infected and fewer lower respiratory tract complications in patients treated with antibiotics as a surrogate for severity than in placebo recipients. However, our Cochrane review found insufficient evidence of a difference between groups for complications classified as serious or leading to patient withdrawal, or for rate of admittance to hospital.

UR - http://www.scopus.com/inward/record.url?scp=84942154585&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(15)00200-7

DO - 10.1016/S0140-6736(15)00200-7

M3 - Letter

VL - 386

SP - 1133

EP - 1134

JO - Lancet

JF - Lancet

SN - 0140-6736

IS - 9999

ER -